[1] |
Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies[J]. Circulation, 1996, 93(5): 841-842.
|
[2] |
中华医学会心血管病学分会, 中国心肌炎心肌病协作组. 中国扩张型心肌病诊断和治疗指南[J]. 临床心血管病杂志, 2018, 34(5): 421-434.
|
[3] |
Perry RJ, Peng L, Cline GW, et al. Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes[J]. Cell Metab, 2018, 27(1): 210-217.
|
[4] |
Frantz S, Fassnacht M, Allolio B, et al, Obesity and heart failure[J]. Internist (Berl), 2008,. 49(4): 389-390, 392-393.
|
[5] |
Samaras K, Connolly SM, Lord RV, et al. Take heart: bariatric surgery in obese patients with severe heart failure. Two case reports[J]. Heart Lung Circ, 2012, 21(12): 847-849.
|
[6] |
WHO, Obesity and overweight [EB/OL].
URL
|
[7] |
Blüher M. Obesity: global epidemiology and pathogenesis[J]. Nat Rev Endocrinol, 2019, 15(5): 288-298.
|
[8] |
Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis[J]. JAMA, 2013, 309(1): 71-82.
|
[9] |
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: A Systematic Review and Meta-analysis [J]. JAMA, 2004, 292(14): 1724-1737.
|
[10] |
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes[J]. N Engl J Med, 2017, 376(7): 641-651.
|
[11] |
Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery[J]. J Card Fail, 2008, 14(3): 198-202.
|
[12] |
WHO, Body mass index - BMI [EB/OL].
URL
|
[13] |
American Society of Anesthesiologists, ASA Physical Status Classification System[EB/OL].
URL
|
[14] |
New York Heart Association, Classes of Heart Failure[EB/OL].
URL
|
[15] |
Ebell MH. Predicting Mortality Risk in Patients Undergoing Bariatric Surgery[J]. Am Fam Physician, 2008, 77(2): 220-221.
|
[16] |
Chen CQ, Wang X, Zhang J, et al. Anesthetic management of patients with dilated cardiomyopathy for noncardiac surgery[J]. Eur Rev Med Pharmacol Sci, 2017, 21(3): 627-634.
|
[17] |
Pelosi P, Croci M, Ravagnan I, et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia[J]. Anesthesia and Analgesia, 1998, 87(3): 654-660.
|
[18] |
邓小明,熊利泽. 中国麻醉学指南与专家共识[M]. 北京:人民卫生出版社, 2017.
|
[19] |
陈日垦, 洪城, 周圆明, 等, 重度睡眠呼吸暂停低通气综合征表现为扩张性心肌病致肺动脉高压一例并文献复习[J]. 中华结核和呼吸杂志, 2017, 40(1): 46-51.
|
[20] |
Cannesson M, Gan TJ. PRO: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol[J]. Anesthesia and Analgesia, 2016, 122(5): 1258-1260.
|
[21] |
Reinius H, Jonsson L, Gustafsson S, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study[J]. Anesthesiology, 2009, 111(5): 979-987.
|
[22] |
车国卫, 吴齐飞, 邱源 等. 多学科围手术期气道管理中国专家共识(2018版)[J]. 中国胸心血管外科临床杂志, 2018, 25(7): 545-549.
|
[23] |
邹启荣,李佳阳,彭雪梅.容量控制通气模式和压力控制通气模式对病态肥胖症患者循环功能的影响[J/CD]. 中华肥胖与代谢病电子杂志, 2015, 1(3): 122-127.
|
[24] |
杨琪瑶, 苏振波, 胡裕, 等. 病态肥胖患者的肺保护性通气方法的研究进展[J]. 中国实验诊断学, 2019, 23(5): 911-915.
|
[25] |
梁辉. 减重代谢手术围手术期管理的几个关键问题[J]. 中国实用外科杂志, 2019, 39(4): 321-325.
|
[26] |
王存川, 张俊昌, 黄上嘉. 肥胖与代谢病外科围手术期管理的思考[J/CD]. 中华普通外科学文献(电子版), 2017, 11(1): 4-8.
|